With no industry pushback, regulators have a clear path to incentivize the deployment of proven technologies that can ...

Antibody therapies are a type of biologic. They are typically monoclonal antibodies selected to bind to a particular protein (often a cell-surface protein), and produced using recombinant DNA ...